Literature DB >> 25523786

Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells.

Ken Kono1, Nozomi Takada2, Satoshi Yasuda3, Rumi Sawada4, Shingo Niimi5, Akifumi Matsuyama6, Yoji Sato7.   

Abstract

The analysis of in vitro cell senescence/growth after serial passaging can be one of ways to show the absence of immortalized cells, which are frequently tumorigenic, in human cell-processed therapeutic products (hCTPs). However, the performance of the cell growth analysis for detection of the immortalized cellular impurities has never been evaluated. In the present study, we examined the growth rates of human mesenchymal stem cells (hMSCs, passage 5 (P = 5)) contaminated with various doses of HeLa cells, and compared with that of hMSCs alone. The growth rates of the contaminated hMSCs were comparable to that of hMSCs alone at P = 5, but significantly increased at P = 6 (0.1% and 0.01% HeLa) or P = 7 (0.001% HeLa) within 30 days. These findings suggest that the cell growth analysis is a simple and sensitive method to detect immortalized cellular impurities in hCTPs derived from human somatic cells.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cellular therapy; Mesenchymal stem cell; Quality; Regenerative medicine; Safety; Tumorigenicity

Mesh:

Year:  2014        PMID: 25523786     DOI: 10.1016/j.biologicals.2014.11.007

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  7 in total

1.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

Review 2.  Principles for establishment of the stem cell bank and its applications on management of sports injuries.

Authors:  Bao-Shi Fan; Yang Liu; Ji-Ying Zhang; You-Rong Chen; Meng Yang; Jia-Kuo Yu
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

3.  Identification of a Gene Encoding Slow Skeletal Muscle Troponin T as a Novel Marker for Immortalization of Retinal Pigment Epithelial Cells.

Authors:  Takuya Kuroda; Satoshi Yasuda; Hiroyuki Nakashima; Nozomi Takada; Satoko Matsuyama; Shinji Kusakawa; Akihiro Umezawa; Akifumi Matsuyama; Shin Kawamata; Yoji Sato
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.

Authors:  Emiko Ito; Shigeru Miyagawa; Maki Takeda; Ai Kawamura; Akima Harada; Hiroko Iseoka; Shin Yajima; Nagako Sougawa; Noriko Mochizuki-Oda; Satoshi Yasuda; Yoji Sato; Yoshiki Sawa
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

5.  Safety study of allogeneic mesenchymal stem cell therapy in animal model.

Authors:  Alvin Man Lung Chan; Angela Min Hwei Ng; Mohd Heikal Mohd Yunus; Ruszymah Bt Hj Idrus; Jia Xian Law; Muhammad Dain Yazid; Kok-Yong Chin; Sharen Aini Shamsuddin; Mohd Rafizul Mohd Yusof; Rabiatul Adawiyah Razali; Mohd Asyraf Mat Afandi; Muhammad Najib Fathi Hassan; See Nguan Ng; Benson Koh; Yogeswaran Lokanathan
Journal:  Regen Ther       Date:  2022-02-17       Impact factor: 3.419

6.  Ultra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formation.

Authors:  Shinji Kusakawa; Satoshi Yasuda; Takuya Kuroda; Shin Kawamata; Yoji Sato
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

7.  Quality assessment tests for tumorigenicity of human iPS cell-derived cartilage.

Authors:  Yoshiaki Takei; Miho Morioka; Akihiro Yamashita; Tomohito Kobayashi; Nobuyuki Shima; Noriyuki Tsumaki
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.